Notably, some studies have shown that vitamin K1 (chlorophylquinone) can compensate for the damage to the anti-ferroptosis defense mechanism when GPX4 was inhibited or when used with the DHODH inhibitor BQR, and its anti-ferroptosis efficacy was found to be equivalent to that of ferrostatin-1 (Fer-1) [61]
Farxiga is the brand name for dapagliflozin, an oral tablet used to treat type 2 diabetes, heart failure, and chronic kidney disease
Gallbladder-related adverse events, including cholelithiasis and cholecystitis, have been reported with GLP-1 receptor agonist therapy
Not approved for diagnostic or therapeutic purposes
Treatment protocols can vary depending on individual goals such as skin brightening, antioxidant support, or general wellness